Yahoo! Deal Kicks O...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$72.94 0.00 | 0.00%
05/20/13 - 04:01 PM ET
4.24M / 3.56M
Vol / Avg. Vol:73.01 / 72.94
Open / Prev. Close:72.81 - 73.95
Today's Range:48.98 - 73.40
52 Wk Range:9.42%
Performance YTD:TheStreet Rating:
Portfolios with BAX
- Portfolio NameUser Type
- UserCAPT JER2
- ContributorTechnical Setups for the We...
- ProBill Frels - Mairs & Power
- ContributorRocket Stocks for the Week ...
- ContributorDividend Stocks for the Wee...
- UserTest
- ContributorMost-Searched Stocks for th...
- ContributorTop-Yielding Health Service...
- ProFarallon Capital Management
- UserDividend Income 2011-11-23
Latest BAX Headlines from TheStreet
- An Investor's Choice: J&J or Baxter International? 04.19.13 | 06:04 am
- 5 Names Seeing Bullish Options Flow 04.18.13 | 12:04 pm
- Baxter International Inc. Stock Buy Recommendation Reiterated (BAX) 04.11.13 | 10:04 am
- Call Buy in Baxter
04.10.13 | 02:04 pm - Baxter International Inc. (BAX): Health Services' Featured Underperformer Of The Day 04.03.13 | 05:04 pm
- 5 Stocks Dragging In The Health Services Industry 04.03.13 | 01:04 pm
- Baxter International Inc. Stock Buy Recommendation Reiterated (BAX) 04.01.13 | 10:04 am
- Today's Stocks Driving Success For The Health Services Industry 03.22.13 | 01:03 pm
- Baxter International Reaches New 52-Week High (BAX) 03.22.13 | 10:03 am
- Baxter International Inc. Stock Buy Recommendation Reiterated (BAX) 03.19.13 | 10:03 am
Press Releases for BAX
- Baxter International First Quarter 2013 Financial Results Conference Call - Business Wire 03.27.13 | 04:03 pm
- Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union - PR Newswire 03.22.13 | 08:03 am
- Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union - Business Wire 03.22.13 | 08:03 am
- Baxter To Present At Raymond James 34th Annual Institutional Investors Conference - Business Wire 02.27.13 | 09:02 am
- Baxter Submits Application For FDA Approval Of FEIBA NF For Prophylactic Use In Hemophilia A And B Patients With Inhibitors - Business Wire 02.26.13 | 09:02 am
- Baxter Declares Quarterly Dividend - Business Wire 02.19.13 | 09:02 am
- Baxter To Present At Upcoming Global Healthcare Conferences - Business Wire 02.07.13 | 04:02 pm
- Baxter Announces Agreement To Acquire Investigational Hemophilia Compound OBI-1 And Related Assets - Business Wire 01.24.13 | 07:01 am
- Baxter Reports Record Sales, Earnings And Cash Flow For Full-Year 2012 - Business Wire 01.24.13 | 07:01 am
- St. Joseph’s/Candler Health System In Savannah, Ga. Receives Prestigious $100,000 Foster G. McGaw Prize For Excellence In Community Service - Business Wire 01.23.13 | 09:01 am
Partner Headlines for BAX
- Pre-Market Earnings Report for April 18, 2013 : PM, VZ, PEP, UNP, UNH, MS, DHR, BAX, FCX, BBT, PPG, TSM - NASDAQ 04.17.13 | 08:04 pm
- MGC Diagnostics Corporation (MGCD) Ex-Dividend Date Scheduled for April 10, 2013 - NASDAQ 04.09.13 | 01:04 pm
- Top Funds' New Buys: Lumber Liquidators, Celgene - Investor's Business Daily 04.02.13 | 06:04 pm
- Covidien plc. (COV) Ex-Dividend Date Scheduled for April 02, 2013 - NASDAQ 04.01.13 | 01:04 pm
- DENTSPLY International Inc. (XRAY) Ex-Dividend Date Scheduled for March 26, 2013 - NASDAQ 03.25.13 | 01:03 pm
- Stryker Corporation (SYK) Ex-Dividend Date Scheduled for March 26, 2013 - NASDAQ 03.25.13 | 01:03 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Common Sense Says Time For Quality, Dividends And Premiums - Seeking Alpha 03.23.13 | 06:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus - Benzinga 03.22.13 | 04:03 pm
